ScholarIQanswers from OpenAlex & ORCID
Hayrettin Tumani
ResearcherPublications, citations & collaboration network
Hayrettin Tumani is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Hayrettin Tumani have?
ScholarIQindexed works
Hayrettin Tumani has 738 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Hayrettin Tumani have?
ScholarIQcitation count
Hayrettin Tumani has 18,067 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Hayrettin Tumani?
ScholarIQh-index
Hayrettin Tumani has an h-index of 71 in OpenAlex.
What is the i10-index of Hayrettin Tumani?
ScholarIQi10-index
Hayrettin Tumani has an i10-index of 231 in OpenAlex.
What is the ORCID of Hayrettin Tumani?
ScholarIQorcid
The ORCID for Hayrettin Tumani is on the source record.
What is the OpenAlex record for Hayrettin Tumani?
ScholarIQopenalex
The OpenAlex for Hayrettin Tumani is on the source record.
What are the most-cited papers on Hayrettin Tumani?
ScholarIQmost cited works
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Ahmed Abdelhak, Matteo Foschi, Samir Abu‐Rumeileh, John K. Yue, Lucio D’Anna, André Huss, Patrick Oeckl, Albert C. Ludolph, Jens Kühle, Axel Petzold, Geoffrey T. Manley, Ari Green, Markus Otto, Hayrettin Tumani
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius, Klemens Ruprecht, Brigitte Wildemann, Tania Kuempfel, Marius Ringelstein, Christian Geis, Ingo Kleiter, Christoph Kleinschnitz, Achim Berthele, Johannes Brettschneider, Kerstin Hellwig, Bernhard Hemmer, Ralf A. Linker, Florian Lauda, Christoph Mayer, Hayrettin Tumani, Arthur Melms, Corinna Trebst, Martin Stangel, Martin Marziniak, Frank Hoffmann, Sven Schippling, Jürgen Faiss, Oliver Neuhaus, Barbara Ettrich, Christian Zentner, Kersten Guthke, Ulrich Hofstadt‐van Oy, Reinhard Reuß, Hannah Pellkofer, Ulf Ziemann, Peter Kern, K.-P. Wandinger, Florian Then Bergh, Tobias Boettcher, Stefan Langel, Martin Liebetrau, Paulus Rommer, Sabine Niehaus, Christoph Münch, Alexander Winkelmann, Uwe K Zettl U, Imke Metz, Christian Veauthier, Jörn Peter Sieb, Christian Wilke, Hans Hartung, Orhan Aktaş, Friedemann Paul
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Tania Kümpfel, Katrin Giglhuber, Orhan Aktaş, Ilya Ayzenberg, Judith Bellmann–Strobl, Vivien Häußler, Joachim Havla, Kerstin Hellwig, Martin W. Hümmert, Sven Jarius, Ingo Kleiter, Luisa Klotz, Markus Krumbholz, Friedemann Paul, Marius Ringelstein, Klemens Ruprecht, Makbule Şenel, Jan‐Patrick Stellmann, Florian Then Bergh, Corinna Trebst, Hayrettin Tumani, Clemens Warnke, Brigitte Wildemann, Achim Berthele, The Neuromyelitis Optica Study Group (NEMOS), Philipp Albrecht, Klemens Angstwurm, Susanna Asseyer, Ana Beatriz Ayroza Galvão Ribeiro Gomes, Antonios Bayas, Stefanie Behnke, Stefan Bittner, Franziska Buetow, Mathias Buttmann, Ankelien Duchow, Daniel Engels, Thorleif Etgen, Katinka Fischer, Benedikt Frank, Anna Gahlen, Achim Gass, Johannes Gehring, Christian Geis, Ralf Gold, Yasemin Göreci, Jonas Graf, Sergiu Groppa, Matthias Grothe, Julia Gutbrod, Kersten Guthke, Axel Haarmann, Maria Hastermann, Bernhard Hemmer, Mariella Herfurth, Marina Herwerth, Frank Hoffmann, Olaf Hoffmann, Martin W. Hümmert, Leila Husseini, Jutta Junghans, Matthias Kaste, Peter Kern, Karsten Kern, Pawel Kermer, Christoph Kleinschnitz, Wolfgang Köhler, Kimberly Körbel, Markus C. Kowarik, Markus Kraemer, Julian Reza Kretschmer, Natalia Kurka, Theodoros Ladopoulus, Ann-Sophie Lauenstein, Sarah Laurent, De-Hyung Lee, Dominik Lehrieder, Frank Leypoldt, Martin Liebetrau, Ralf A. Linker, Gero Lindenblatt, Lisa Lohmann, Felix Lüssi, Peter Luedemann, Michelle Maiworm, Martin Marziniak, Christoph Mayer, Stefanie Meister, Mathias Mering, Imke Metz, Sven G. Meuth, Jasmin Naumann, Oliver Neuhaus, Tradite Neziraj, Moritz Niederschweiberer, Sabine Niehaus, Carolin Otto, Florence Pache, Thivya Pakeerathan, Sarah Passoke, Marc Pawlitzki
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
Sven Jarius, Orhan Aktaş, Ilya Ayzenberg, Judith Bellmann–Strobl, Achim Berthele, Katrin Giglhuber, Vivien Häußler, Joachim Havla, Kerstin Hellwig, Martin W. Hümmert, Ingo Kleiter, Luisa Klotz, Markus Krumbholz, Tania Kümpfel, Friedemann Paul, Marius Ringelstein, Klemens Ruprecht, Makbule Şenel, Jan‐Patrick Stellmann, Florian Then Bergh, Hayrettin Tumani, Brigitte Wildemann, Corinna Trebst, Neuromyelitis Optica Study Group (NEMOS)
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuß, Ralf A. Linker, Mathias Mäurer, Orhan Aktaş, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czapliński, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans‐Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding‐Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp, for the ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG)